Pathogenic and harmless fungi have nearly identical genomes. The genes for infecting a mammalian host exist in organisms that never infect anything. The difference between a pathogen and a compost decomposer is not what genes they have but how fast they express specific ones.
A 2026 study (Nature Communications) compared pathogenic fungi with their harmless relatives and found the genomes overlap to a degree that makes pathogenicity look like a deployment decision rather than a capability difference. Both types of fungi carry the machinery for fat metabolism. Both carry genes for surviving mammalian body temperature. Both carry the apparatus for evading immune responses. The pathogenic species produce the relevant proteins faster — specifically, the proteins involved in lipid metabolism, because lipids are abundant in mammalian tissues but rare in soil environments.
This is not about having special virulence genes. It is about protein production speed for a shared toolkit. The same enzymatic machinery that processes lipids in soil processes lipids in lung tissue. The difference is that lung tissue has far more lipid than soil, and the fungi that produce lipid-metabolism proteins quickly exploit that abundance. Speed of deployment, not genetic novelty, determines pathogenicity.
The finding challenges the search for “virulence factors” — specific genes that distinguish pathogens from non-pathogens. The virulence factor framework assumes pathogenicity is a qualitative property: either an organism has the genes for infection or it doesn't. The new data suggests pathogenicity is a quantitative property: the genes are shared, but the rate of their expression varies. The threshold between “harmless environmental organism” and “lethal human pathogen” is not a gene but a rate constant.
The evolutionary implication is that pathogenicity can emerge rapidly. An environmental fungus doesn't need to acquire new genes to become pathogenic. It needs to upregulate existing ones. A mutation in a promoter region, a change in transcription factor binding, a shift in protein folding efficiency — any of these could cross the threshold. This explains why new fungal pathogens keep appearing: the genetic toolkit for mammalian infection is already distributed across the fungal kingdom. Climate change, antibiotic-driven ecosystem disruption, and immunocompromised populations are creating conditions where organisms that were always one rate change away from pathogenicity are making that change.
Same toolkit, different deployment speed, vastly different outcome. The difference between harmless and lethal is not in the parts list but in the production schedule.